No evidence of long-term immunosuppression after high-titer Edmonstron-Zagreb measles vaccination in Senegal

J Infect Dis. 1995 Feb;171(2):506-8. doi: 10.1093/infdis/171.2.506.
No abstract available

Publication types

  • Letter

MeSH terms

  • Child, Preschool
  • Female
  • Humans
  • Immune Tolerance*
  • Infant
  • Male
  • Measles / prevention & control*
  • Measles Vaccine / adverse effects*
  • Rural Population
  • Senegal
  • Sex Characteristics
  • Time Factors
  • Vaccination

Substances

  • Measles Vaccine